Evidence map›Paper›PMID 39077684›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Amyloid beta-independent sleep markers associated with early regional tau burden and cortical thinning.

Laura Stankeviciute, Jasmeer P Chhatwal, Raina Levin, Valentina Pinilla, Aaron P Schultz, Susan Redline, Keith A Johnson, Reisa A Sperling, Nataliia Kozhemiako, Shaun Purcell and 1 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Long-term forgetting, sleep, and tau in autosomal-dominant Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  6. Article
  7. Article
  8. Sleep Abnormalities and Risk of Alzheimer's Disease.Current neurology and neuroscience reports · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laura StankeviciuteDepartment of Neurology Brigham and Women's Hospital Boston Massachusetts USA.
Jasmeer P ChhatwalDepartment of Neurology Brigham and Women's Hospital Boston Massachusetts USA.
Raina LevinMassachusetts General Hospital Boston Massachusetts USA.
Valentina PinillaMassachusetts General Hospital Boston Massachusetts USA.
Aaron P SchultzMassachusetts General Hospital Boston Massachusetts USA.
Susan RedlineMassachusetts General Hospital Boston Massachusetts USA.
Keith A JohnsonDepartment of Neurology Brigham and Women's Hospital Boston Massachusetts USA.
Reisa A SperlingDepartment of Neurology Brigham and Women's Hospital Boston Massachusetts USA.
Nataliia KozhemiakoDepartment of Neurology Brigham and Women's Hospital Boston Massachusetts USA.
Shaun PurcellDepartment of Neurology Brigham and Women's Hospital Boston Massachusetts USA.
Ina DjonlagicDepartment of Neurology Brigham and Women's Hospital Boston Massachusetts USA.ORCID https://orcid.org/0000-0002-6951-3862

Funding

Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)P01AG036694 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Rebecca E Amariglio · 2010 to 2026
$50.2M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's DiseaseR01AG062667 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI CHHATWAL, JASMEER P · 2019 to 2024
$4.2M
NIA NIH HHS P01 AG036694NIA NIH HHS P30 AG062421NIA NIH HHS R01 AG062667
6 · The paper itself

Abstract

introductionSleep is crucial for memory consolidation and the clearance of toxic proteins associated with Alzheimer's disease (AD). We examined the association between sleep characteristics and imaging biomarkers of early amyloid beta (Aβ) and tau pathology as well as neurodegeneration in brain regions known to be affected in the incipient stages of AD.

methodsThirty-nine cognitively unimpaired (CU) participants of the Harvard Aging Brain Study underwent at-home polysomnography as well as tau positron emission tomography (flortaucipir-PET), amyloid PET (Pittsburgh compound B [PiB]-PET), and magnetic resonance imaging-derived assessment of cortical thickness (CT).

resultsIncreased N1 sleep was associated with a higher tau PET signal (β = 0.009, DISCUSSION: In CU older adults, lower SWS and higher N1 sleep were associated with higher tau burden and lower CT in brain regions associated with early tau deposition and vulnerable to AD-related neurodegeneration through mechanisms dissociable from amyloid deposition. Highlights: We report the results of an observational study, which leveraged -a well-characterized cohort of healthy aging (Harvard Aging Brain Study) by adding in-home full polysomnograms.By adding at-home polysomnograms to this unique and deeply phenotyped cohort, we examined variations in sleep architecture that are associated with Alzheimer's disease (AD) pathologic changes.Our results confirmed the association of sleep changes with early tau and cortical neurodegenerative changes that were independent of amyloid.The results will be of importance in monitoring sleep-related variations in relation to the natural history of AD pathology and in designing sleep-focused clinical trials.

Indexed as

amyloid positron emission tomographyneurodegenerationneuroimagingslow‐wave sleeptau pet

Identifiers

PMID39077684
PMCPMC11284643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.